TCL Archive “Alternative” Is Misleading Term, President’s Cancer Panel Writes To Healy February 5, 1993
TCL Archive FDA Advisors Unanimously Turn Down GPC Biotech’s Orplatna for Prostate Cancer. July 27, 2007
TCL Archive Harlow, Abeloff To Chair BSC Subcommittees; Livingston To Head Extramural Advisors September 15, 1995